BioSpace News Archive

Oral health non-profits FDI World Dental Federation (FDI) and Smile Train are joining forces with support from GSK Consumer Healthcare to launch a two-year project to improve oral health guidance and on-going care for children with clefts.

Ryusuke Fujiki, Clinical Head and President of Fujiki Hospital, lectured about multidisciplinary approaches which are getting remarkable effect to minimally invasive cancer treatment using JCI MN Colloidal Iodine.

Occlutech AG announced that its atrial flow regulator, the Occlutech AFR device, has obtained CE mark approval clearing it for sales on the European CE regulated market.

Aurinia Pharmaceuticals Inc. announced that Peter Greenleaf, President and Chief Executive Officer of Aurinia, will present a corporate overview at the 21st Annual H.C. Wainwright Global Investment Conference on Monday, September 9, 2019 at 12:30pm ET in New York, NY.

Windtree Therapeutics, Inc. (OTCQB: WINT), today announced the full publication of previously described results of a lung deposition study conducted in non-human primates (NHPs) that demonstrated the Company’s proprietary aerosol delivery system (ADS) is capable of delivering aerosolized lucinactant (the Company’s lyophilized KL4 surfactant) throughout all regions of the lung.

The global robotics market continues to shift increasingly toward non-industrial robots.

OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced that Daniel J. O’Connor, President and Chief Executive Officer of OncoSec, will present a company overview at the 21st Annual H.C. Wainwright Global Investment Conference on Monday, September 9, 2019

Hoth Therapeutics, Inc. (Nasdaq: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chronic wound disorders, today announced that Robb Knie, Chief Executive Officer, will be presenting at the H.C. Wainwright 21st Annual Global Investment Conference in New York

Abbott (NYSE: ABT) announced today that it is teaming up with NFL star, Cleveland Browns wide receiver, and Pedialyte® fan, Odell Beckham Jr., to serve as a creative director and ambassador for Pedialyte

Medicine Man Technologies, Inc. (OTCQX: MDCL) (“Medicine Man Technologies” or the “Company”), is pleased to announce its latest binding term sheet to acquire Roots Rx, a cannabis operator with six dispensaries located in the ski and mountain towns of Colorado